Stem cell transplant study for myeloma halted early
Disease control
Terminated
This study looked at whether a donor stem cell transplant (allogeneic) could help people with multiple myeloma whose cancer returned after initial treatment. It compared this approach to continuing standard drug therapy. The trial was stopped early and included 28 adults aged 18 …
Phase: PHASE3 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC